1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Total Occlusion Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution /Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Sales Analysis of Major Micro Catheter Brands, 2022
5.2. Sales Analysis of Major Guide Wires Brands, 2022
5.3. Sales Analysis of Major Crossing Device Brands, 2022
5.4. Technological Advancements
5.5. Disease Prevalence & Incidence Rate globally with key countries
5.6. Regulatory Scenario by Region/globally
5.7. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Microcatheters
6.3.2. Guidewires
6.3.3. Balloon Catheters
6.3.4. Crossing Devices
6.3.5. Stents
6.3.6. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Total Occlusion Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2031
9.2.1. Microcatheters
9.2.2. Guidewires
9.2.3. Balloon Catheters
9.2.4. Crossing Devices
9.2.5. Stents
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Microcatheters
10.2.2. Guidewires
10.2.3. Balloon Catheters
10.2.4. Crossing Devices
10.2.5. Stents
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Microcatheters
11.2.2. Guidewires
11.2.3. Balloon Catheters
11.2.4. Crossing Devices
11.2.5. Stents
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Microcatheters
12.2.2. Guidewires
12.2.3. Balloon Catheters
12.2.4. Crossing Devices
12.2.5. Stents
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Microcatheters
13.2.2. Guidewires
13.2.3. Balloon Catheters
13.2.4. Crossing Devices
13.2.5. Stents
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Type Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Boston Scientific Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Type Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Abbott
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Type Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Asahi Intecc Co., Ltd
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Type Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Acrostak Int. Distr. Sàrl
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Type Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Cook Medical
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Type Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Koninklijke Philips N.V
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Type Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Terumo Corporation
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Type Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Teleflex Incorporated
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Type Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Becton, Dickinson and Company
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Type Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Reflow Medical, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Type Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Cordis
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Type Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
Table 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031